Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing

dc.contributor.author	Farrell, Barbara
dc.contributor.author	Pottie, Kevin
dc.contributor.author	Rojas-Fernandez, Carlos H.
dc.contributor.author	Bjerre, Lise M.
dc.contributor.author	Thompson, Wade
dc.contributor.author	Welch, Vivian
dc.date.accessioned	2019-03-27T14:49:16Z
dc.date.available	2019-03-27T14:49:16Z
dc.date.issued	2016
dc.description.abstract	Class specific deprescribing guidelines could help clinicians taper and stop medications no longer needed or which may be causing more harm than benefit. We set out to develop methodology to create such guidelines using evidence-based methods for guideline development, evidence synthesis and recommendation rating.	en_US
dc.identifier.doi	10.1371/journal.pone.0161248	en_US
dc.identifier.issn	1932-6203	en_US
dc.identifier.uri	https://doi.org/10.20381/ruor-23227
dc.identifier.uri	http://hdl.handle.net/10393/38977
dc.language.iso	en	en_US
dc.subject	Drug Prescriptions	en_US
dc.subject	Drug-Related Side Effects and Adverse Reactions	en_US
dc.subject	Humans	en_US
dc.subject	Practice Guidelines as Topic	en_US
dc.subject	Deprescriptions	en_US
dc.subject	Evidence-Based Medicine	en_US
dc.subject	Health Services Needs and Demand	en_US
dc.title	Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing	en_US
dc.type	Article	en_US

Fichiers

Voici les éléments 1 - 1 sur 1

Voici les éléments 1 - 1 sur 1